Search Result "PI3/Akt/mTOR"
Potential Molecular Targeted Therapeutics: Role of PI3-K/Akt/mTOR Inhibition in Cancer
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16 Issue: 1 Year: 2016 Page: 29-37
Author(s): Kevin M. Sokolowski,Steven Koprowski,Selvi Kunnimalaiyaan,Mariappan Balamurugan,T. Clark Gamblin,Muthusamy Kunnimalaiyaan
Dual Inhibition of PI3-Kinase and mTOR in Renal Cell Carcinoma
Journal: Current Cancer Drug Targets
Volume: 13 Issue: 2 Year: 2013 Page: 126-142
Author(s): Daniel C. Cho, James W. Mier
Inhibition of Akt/mTOR Signaling by the Dietary Flavonoid Fisetin
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13 Issue: 7 Year: 2013 Page: 995-1001
Author(s): Deeba N. Syed, Vaqar M. Adhami, Mohammad Imran Khan, Hasan Mukhtar
Identification of Multi-kinase Allosteric Inhibitors of Oncogenic TargetsEGFR1, PI3K, and BRAF Kinase
Journal: Current Computer-Aided Drug Design
Volume: 18 Issue: 7 Year: 2022 Page: 506-518
Author(s): Kavita Kumari Kakarala
Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin
Journal: Current Cancer Drug Targets
Volume: 16 Issue: 4 Year: 2016 Page: 288-304
Author(s): Zhipeng Zou,Juan Chen,Jun Yang,Xiaochun Bai
Extracellular Matrix and Aberrant Signaling in Lung Carcinoma: Role of Fibronectin in the Control of Human Lung Carcinoma Cell Growth,Apoptosis and Resistance to Therapy
Journal: Current Signal Transduction Therapy
Volume: 2 Issue: 1 Year: 2007 Page: 1-10
Author(s): Shou Wei Han, Jesse Roman
The Role of Tregs in Cancer: Foxp3 as a Putative Target for Therapy
Journal: Current Signal Transduction Therapy
Volume: 4 Issue: 2 Year: 2009 Page: 122-129
Author(s): Brendan Meyer, Wai M. Liu, Angus G. Dalgleish, Christine Galustian
The Role of Adipokines in the Establishment and Progression of Head and Neck Neoplasms
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 25 Year: 2019 Page: 4726-4748
Author(s): Theodora Tzanavari,Jason Tasoulas,Chrysoula Vakaki,Chrysovalantou Mihailidou,Gerasimos Tsourouflis,Stamatios Theocharis
The PIK3CA Gene as a Mutated Target for Cancer Therapy
Journal: Current Cancer Drug Targets
Volume: 8 Issue: 8 Year: 2008 Page: 733-740
Author(s): John P. Gustin, David P. Cosgrove, Ben Ho Park
Recent Development in Indole Derivatives as Anticancer Agent: A Mechanistic Approach
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 21 Issue: 14 Year: 2021 Page: 1802-1824
Author(s): Neha Devi,Kamalpreet Kaur,Avadh Biharee,Vikas Jaitak